Yale Cancer Biology Institute
The Yale Cancer Biology Institute connects scientists from across Yale to study the common underlying causes of cancer, wherever it appears. Traditional cancer research continues to focus on vital questions about the treatment and care of specific types of cancer. Complementing this work, today’s research also seeks to understand core cellular and molecular links across multiple cancers. The purpose of the Cancer Biology Institute is to study this core biology.
Meet the labs of the Yale Cancer Biology Institute
-
Alarcón Lab
Uncovering the physiological and pathophysiological roles of RNA modifications at the molecular, cellular, and organism level through multidisciplinary approaches
-
Ferguson Lab
Defining therapeutic opportunities with growth factor receptors using structure
-
Kabeche Lab
Understanding the interplay between chromosomal instability and DNA damage response defects in cancers to uncover new cancer therapy targets
-
Klein Lab
Deciphering the structural underpinnings of oncogene activation to inform the rational design of antibody therapeutics
-
LaMarche Lab
We combine high-dimensional profiling of cancer patient tissues with detailed mechanistic studies in mouse models to develop new immunotherapies for solid tumors
-
Lemmon Lab
Understanding receptor tyrosine kinase signaling and how to correct aberrant activity when altered in diseases such as cancer
-
Liu Lab
Studying proteomics, protein turnover, and post-translational modifications to understand cancer aneuploidy, cellular signaling transduction, and biodiversity
-
Muzumdar Lab
Deciphering how genetic alterations interact with environmental and host factors to drive cancer development
-
Schlessinger Lab
Analyzing the mode of action of growth factor receptors and the intracellular signaling pathways that activated in response to growth factor stimulation
Upcoming Events
YCBI News
-
Protein turnover mapping may offer clues for Alzheimer’s, cancer treatment
The lab of Yansheng Liu has uncovered potential targets for treating Alzheimer’s disease and cancer
-
Yale scientists decode chemical transmitter for clues to new cancer therapies
Yale Cancer Biology Institute scientists have redefined the role of a unique chemical receptor, opening the way for new targeted cancer therapies
-
Lilian Kabeche recognized for excellence in research by an Historically Excluded Person
The award is presented to early-career scientists who self-identify as Historically Excluded Persons
